Developing and Assessing a Male Engagement Intervention for Option B+ in Malawi

在马拉维制定和评估选项 B 的男性参与干预措施

基本信息

  • 批准号:
    9025583
  • 负责人:
  • 金额:
    $ 8.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Candidate: I am an infectious diseases epidemiologist committed to reducing HIV incidence in resource- limited settings through combination HIV prevention. My career goal is to be an epidemiology professor with a robust combination HIV prevention research portfolio. As an epidemiologist with behavioral science exposure, I am well positioned to achieve this goal. However, to compete successfully for R01 funding, I would benefit from a brief period of mentored training and research. I have extensive experience in the design and analysis of behavioral research, but limited experience in the design and delivery of theory-driven behavioral interventions. In a two-year mentored phase, both my training and research activities will focus on cultivating skills for designing and delivering theory-driven behavioral intervention. I have assembled an exceptional team of mentors to support this goal: Dr. William C. Miller (primary mentor), Dr. Mina Hosseinipour (primary co- mentor), and Drs. Nuala McGrath, Carol Golin, and Suzanne Maman (co-mentors). All members of the team have prolific scientific accomplishments and extensive experience in the design, implementation and evaluation of combination HIV prevention approaches in sub-Saharan Africa. They are committed to supporting me and collaborating with each other. Mentored Phase Research (K99, years 1-2): In sub-Saharan Africa, strategies to increase HIV testing among men and engage them in HIV prevention, care, and treatment are urgently needed. Such engagement can have treatment benefits for HIV-infected men, prevention benefits for HIV-uninfected men, and treatment benefits for their HIV-infected female partners. Option B+, Malawi s program for providing immediate, lifelong combination antiretroviral therapy (cART) to all HIV-infected pregnant women at the time of diagnosis, is a promising setting for engaging male partners in care. Within Option B+, I will develop an intervention that uses contract partner notification to recruit male partners and then engage them in a couple-based intervention with their HIV-infected female partner (Aim 1). The intervention will be guided by formative research and the dyad-level Interdependence Theory and aimed at improving linkage to care for HIV-infected male partners, preventing HIV acquisition for HIV-uninfected male partners, and promoting cART retention for HIV-infected female partners. Independent Phase Research (R00, Years 3-5): I will conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at one year. I will assess whether the intervention increases HIV testing and linkage to care among HIV-infected male sex partners (Aim 2); identifies HIV-discordant couples, and decreases the likelihood of HIV exposure for HIV- uninfected male sex partners (Aim 3); and improves cART retention and viral suppression for all female partners (Aim 4). Future Directions: The R00 results will inform an R01 with longer-term viral suppression and HIV-incidence outcomes. I will transition from a mentored postdoctoral research associate to an independent investigator capable of designing behavioral interventions and leading combination HIV prevention trials.
描述(由申请人提供): 候选人:我是一名传染病流行病学家,致力于在资源有限的情况下通过组合艾滋病毒预防来减少艾滋病毒发病率。我的职业目标是成为一名流行病学教授,拥有强大的艾滋病毒预防研究组合。作为一名有行为科学经验的流行病学家,我完全有能力实现这一目标。然而,为了成功竞争R01的资金,我将受益于短暂的指导培训和研究。我在行为研究的设计和分析方面有丰富的经验,但在设计和提供理论驱动的行为干预方面经验有限。在为期两年的指导阶段,我的培训和研究活动都将侧重于培养设计和提供理论驱动的行为干预的技能。我召集了一支杰出的导师团队来支持这一目标:威廉·C·米勒博士(主要导师)、米娜·侯赛尼普尔博士(主要共同导师)、Nuala McGrath博士、Carol Golin博士和Suzanne Maman博士(共同导师)。该小组的所有成员在设计、实施和评估撒哈拉以南非洲艾滋病毒综合预防方法方面都有丰富的科学成就和丰富的经验。他们致力于支持我并相互合作。指导阶段研究(K99,第1-2年):在撒哈拉以南非洲,迫切需要增加男子艾滋病毒检测并使他们参与艾滋病毒预防、护理和治疗的战略。这种参与可以为感染艾滋病毒的男性带来治疗好处,为未感染艾滋病毒的男性带来预防好处,并为他们感染艾滋病毒的女性伴侣提供治疗好处。方案B+,马拉维S方案,在确诊时为所有感染艾滋病毒的孕妇提供即时、终身联合抗逆转录病毒疗法(CART),是吸引男性伴侣参与护理的一个有希望的环境。在选项B+中,我将制定一项干预措施,使用合同合作伙伴通知来招聘 然后让他们与感染艾滋病毒的女性伴侣进行以夫妇为基础的干预(目标1)。这项干预措施将以形成性研究和二元水平相互依赖理论为指导,旨在改善联系,以照顾感染艾滋病毒的男性伴侣,防止未感染艾滋病毒的男性伴侣感染艾滋病毒,并促进感染艾滋病毒的女性伴侣保留购物车。 独立阶段研究(R00,第3-5年):我将进行一项随机对照试验(N=500对夫妇),以评估一年的干预效果。我将评估干预措施是否增加了艾滋病毒感染的男性性伴侣中的艾滋病毒检测和与护理的联系(目标2);查明艾滋病毒不和谐的夫妇,并降低未感染艾滋病毒的男性性伴侣接触艾滋病毒的可能性(目标3);以及改善所有女性伴侣的购物车保留率和病毒抑制(目标4)。未来方向:R00的结果将为R01提供更长期的病毒抑制和艾滋病毒发病率结果。我将从一名有指导的博士后助理研究人员转变为一名独立调查员,能够设计行为干预措施并领导艾滋病毒预防组合试验。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Can cash help eliminate mother-to-child HIV transmission?
现金可以帮助消除艾滋病毒母婴传播吗?
  • DOI:
    10.1016/s2352-3018(16)00003-5
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pettifor,Audrey;Rosenberg,Nora;Bekker,Linda-Gail
  • 通讯作者:
    Bekker,Linda-Gail
Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.
  • DOI:
    10.1097/qai.0000000000001273
  • 发表时间:
    2017-04-15
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cataldo F;Chiwaula L;Nkhata M;van Lettow M;Kasende F;Rosenberg NE;Tweya H;Sampathkumar V;Hosseinipour M;Schouten E;Kapito-Tembo A;Eliya M;Chimbwandira F;Phiri S;PURE Malawi Consortium
  • 通讯作者:
    PURE Malawi Consortium
The effectiveness of interventions to improve uptake and retention of HIV-infected pregnant and breastfeeding women and their infants in prevention of mother-to-child transmission care programs in low- and middle-income countries: protocol for a systemati
低收入和中等收入国家提高感染艾滋病毒的孕妇和母乳喂养妇女及其婴儿的干预措施在预防母婴传播护理计划中的有效性:系统性协议
  • DOI:
    10.1186/s13643-015-0136-x
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    PuchalskiRitchie,LisaM;vanLettow,Monique;Hosseinipour,MinaC;Rosenberg,NoraE;Phiri,Sam;Landes,Megan;Cataldo,Fabian;Straus,SharonE;PUREconsortium
  • 通讯作者:
    PUREconsortium
Recruiting the social contacts of patients with STI for HIV screening in Lilongwe, Malawi: process evaluation and assessment of acceptability.
在马拉维利隆圭招募性传播感染患者的社会联系人进行艾滋病毒筛查:过程评估和可接受性评估。
  • DOI:
    10.1136/sextrans-2015-052496
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Rosenberg,NoraE;Stanley,ChristopherC;Rutstein,SarahE;Bonongwe,Naomi;Kamanga,Gift;Pettifor,Audrey;Mapanje,Clement;Martinson,Francis;Hoffman,IrvingF;Miller,WilliamC
  • 通讯作者:
    Miller,WilliamC
Information management in Malawi's prevention of Mother-to-Child Transmission (PMTCT) Program: Health workers' perspectives.
马拉维预防母婴传播 (PMTCT) 计划的信息管理:卫生工作者的观点。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nora Rosenberg其他文献

Nora Rosenberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nora Rosenberg', 18)}}的其他基金

Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
  • 批准号:
    10762645
  • 财政年份:
    2023
  • 资助金额:
    $ 8.4万
  • 项目类别:
Developing a risk assessment tool to identify HIV-uninfected adolescent girls and young women at highest risk for HIV infection: a key step for targeted biomedical HIV prevention
开发风险评估工具来识别艾滋病毒感染风险最高的未感染艾滋病毒的少女和年轻妇女:有针对性的生物医学艾滋病毒预防的关键步骤
  • 批准号:
    10252155
  • 财政年份:
    2021
  • 资助金额:
    $ 8.4万
  • 项目类别:
Developing a risk assessment tool to identify HIV-uninfected adolescent girls and young women at highest risk for HIV infection: a key step for targeted biomedical HIV prevention
开发风险评估工具来识别艾滋病毒感染风险最高的未感染艾滋病毒的少女和年轻妇女:有针对性的生物医学艾滋病毒预防的关键步骤
  • 批准号:
    10375594
  • 财政年份:
    2021
  • 资助金额:
    $ 8.4万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10082594
  • 财政年份:
    2020
  • 资助金额:
    $ 8.4万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10222533
  • 财政年份:
    2020
  • 资助金额:
    $ 8.4万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10873493
  • 财政年份:
    2020
  • 资助金额:
    $ 8.4万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: an implementation science study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10599580
  • 财政年份:
    2020
  • 资助金额:
    $ 8.4万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10626785
  • 财政年份:
    2020
  • 资助金额:
    $ 8.4万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10405504
  • 财政年份:
    2020
  • 资助金额:
    $ 8.4万
  • 项目类别:
Developing and Assessing a Male Engagement Intervention for Option B+ in Malawi
在马拉维制定和评估选项 B 的男性参与干预措施
  • 批准号:
    8846733
  • 财政年份:
    2015
  • 资助金额:
    $ 8.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了